Cargando…
Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy
BACKGROUND: Neoadjuvant chemotherapy has been applied worldwide to improve the survival of patients with gastric adenocarcinoma (GAC). The evaluation of histological regression in primary tumors is valuable for predicting prognosis. However, the prognostic effect of regression change in lymph nodes...
Autores principales: | Zhu, Yue-Lu, Sun, Yong-Kun, Xue, Xue-Min, Yue, Jiang-Ying, Yang, Lin, Xue, Li-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451926/ https://www.ncbi.nlm.nih.gov/pubmed/30984350 http://dx.doi.org/10.4251/wjgo.v11.i1.48 |
Ejemplares similares
-
Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021) -
Metastatic lymph nodes and prognosis assessed by the number of retrieved lymph nodes in gastric cancer
por: Wang, Hao, et al.
Publicado: (2022) -
Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer
por: Chu, Yu-Ning, et al.
Publicado: (2019) -
New metastatic lymph node classification for early gastric cancer should differ from those for advanced gastric adenocarcinoma: Results based on the SEER database
por: Lin, Jian-Xian, et al.
Publicado: (2019) -
Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study
por: Li, Yang, et al.
Publicado: (2020)